In 2021, the FDA approved a higher dose of Ozempics base ingredient, semaglutide, under the name Wegovy, to treat obesity
Missing occasional doses wont derail progress, but consistent daily administration produces best results
Tirzepatide may produce more favorable hormonal changes, different gastrointestinal side effect profiles, or additional metabolic benefits through GIP receptor activation that contribute to better sexual health outcomes
Fluid, hormonal cycles, salt intake and bowel habit all move the number on the scales independently of fat loss
According to Hanes on the Rogan episode, that November visit was the only time he has used BPC-157